Different Clinical Utility of Oropharyngeal Bacterial Screening prior to Percutaneous Endoscopic Gastrostomy in Oncological and Neurological Patients

Table 2

Pathogenic microbial agents colonizing oropharynx or airways in PEG patients and agents isolated from PEG wound in patients with clinically apparent infection.

	Colonizing	Agents	PEG wound infection
	All 274 pts	Neurological/cancer (206/68 pts)	Neurological/cancer (18/12 pts)
Ps. Aeruginosa (R)	63	61/2	1/0
Candida sp. (R)	23	16/7	2/3
MRSA (R)	11	11/0	3/0
Klebsiella sp. ESBL (R)	9	9/0	2/1
Enterobacter sp. (R)	4	2/2	2/1
Klebsiella sp. (S)	33	25/8	7/0
MSSA (S)	26	20/6	4/5
Citrobacter sp. (R)	2	1/1	0/0
Proteusmirabilis (S)	14	12/2	3/1
Acinetobacter sp. (S)	10	6/4	0/0
E. coli (S)	12	9/3	1/1
Enterococcus  faecalis (S)	6	6/0	0/1
Streptococ beta hemolytic (S)	6	0/6	2/2
Polymicrobial	86	75/11	14/10

(R): amoxicillin resistant (S) amoxicillin sensitive, MRSA: methicillin resistant Staphylococcus aureus, MSSA: methicillin sensitive Staphylococcus aureus.